Home » Topics » HIV/AIDS, BioWorld Science

HIV/AIDS, BioWorld Science
RSS

Pharmacia & Upjohn seeks FDA approval for Rescriptor

July 19, 1996

Whole-body extracorporeal hyperthermia trials enter phase II

July 12, 1996

AIDS Research Highlights (July 7-12, Vancouver)

July 12, 1996

Positive efficacy/safety profile for liposomal formulation of DaunoXome

July 12, 1996

3TC/AZT combination phase II/III trial results published

July 12, 1996

Acemannan ineffective on surrogate markers

July 12, 1996

New formulaton of Videx launched in Canada

July 12, 1996

Zerit reaches Canadian market

July 12, 1996

Abbott presents HIV RNA-reducing drug combinations

July 12, 1996

Enzo Biochem, St. Luke's collaborate on gene therapy for AIDS

July 5, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...